Dror Ortho-Design, Inc. 10-Q

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS The following discussion and analysis should be read in conjunction with the audited Financial Statements and accompanying notes thereto included in the Company’s Annual Report on Form 10-K as of and for the fiscal year ended December 31, 2022. Unless otherwise noted, all the financial information in this Report is financial information for the Company . Overview Novint Technologies, Inc. (“Novint”, the “Company”, “we”, “our”, “us”) was originally incorporated in the State of New Mexico in April 1999. On February 26, 2002, the Company changed its state of incorporation to Delaware by merging with Novint Technologies, Inc., a Delaware corporation. This merger was accounted for as a reorganization. Nature of Business The Company currently is engaged in the sale of 3D haptics products and equipment. Haptics refers to one’s sense of touch. The Company’s focus is on the consumer interactive computer gaming market, but the Company conducts project work in non-gaming areas as well. Our principal product is the Falcon, an extensible, grounded (e.g., desktop), three-dimensional (3D) haptic interaction device with characteristics optimized for real-time force-feedback and tactile interaction. Additionally, we have developed but not yet commercialized the Xio product, a next generation, full arm, game controller with forced feedback. Currently, we are focused on engaging in discussions with potential partners and studying other ways to realize value from the Falcon and Xio products. Results of Operations for the Three Months Ended March 31, 2023 and 2022 Revenues Three months ended March 31, 2023 2022 Change Revenue $ — $ — $ — The Company recorded revenue of $0 and $0 for the three-month period ended March 31, 2023 and March 31, 2022. The Company expects to continue to incur significant expenses and operating losses for the foreseeable future. The Company’s net losses may fluctuate significantly from quarter to quarter and year to year. Operating Expenses Three months ended March 31, 2023 2022 Change Operating Expenses $ 50,379 $ 49,300 $ 1,079 Operating expenses increased by $1,079 or 2% to $50,379 for the three months ended March 31, 2023, from $49,300 for the three months ended March 31, 2022. This increase was primarily due to an increase in professional fees incurred during the three months ended March 31, 2023. 10 Other Expense Three months ended March 31, 2023 2022 Change Other Expense $ — $ 14 $ (14 ) Other expense decreased by $14 or 100% to $0 during the three months ended March 31, 2023 compared with $14 during the three months ended March 31, 2022. Other expense for the three months ended March 31, 2022 consisted of interest expense related to finance charges on credit cards which was fully paid off during the period ended March 31, 2022. Liquidity and Capital Resources The following table summarizes select Balance Sheet and working capital amounts as of March 31, 2023 and December 31, 2022: March 31, December 31, 2023 2022 Change Cash $ 23,356 $ 55,081 $ (31,725 ) Working capital deficit $ (774,235 ) $ (723,856 ) $ (50,379 ) At March 31, 2023, the Company had a working capital deficit of approximately $774,235. Accumulated deficit amounted to $41,853,759 and $41,803,380 at March 31, 2023 and December 31, 2022, respectively. Net loss for the three months ended March 31, 2023 and 2022 was $50,379 and $49,314, respectively. Net cash used in operating activities was $31,725 and $38,788 for the three months ended March 31, 2023 and 2022, respectively. Operations since inception have been funded primarily with the proceeds from equity and debt offerings. As of March 31, 2023, the Company had cash of $23,356. The Company’s management has evaluated whether there is substantial doubt about the Company’s ability to continue as a going concern and has determined that substantial doubt existed as of the date of this filing. This determination was based on the following factors: (i) the Company’s available cash as of the date of this filing will not be sufficient to fund its anticipated level of operations for the next 12 months; (ii) the Company has incurred recurring losses and at March 31, 2023, had an accumulated deficit of $41,853,759; (iii) the Company sustained an operating loss of $50,379 for the period ended March 31, 2023; and (iv) if the Company fails to obtain the needed capital, it will be forced to delay, scale back, or eliminate some or all of its programs or perhaps cease operations. In the opinion of management, these factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern. There is no assurance that the Company will be successful in any capital-raising efforts that it may undertake to fund operations during 2023. The Company anticipates that it will continue to issue equity and/or debt securities as a source of liquidity, until it begins to generate positive cash flow to support its operations. Any future sales of securities to finance operations will dilute existing stockholders’ ownership. The Company cannot guarantee when or if it will generate positive cash flow. The audit report prepared by our independent registered public accounting firm relating to the Company’s consolidated financial statements for the year ended December 31, 2022 included an explanatory paragraph expressing substantial doubt about our ability to continue as a going concern. Cash Flow Activities The following table summarizes the Company’s cash flows for the periods set forth below: Three months ended March 31, 2023 2022 Change Net cash used in operating activities $ 31,725 $ 38,788 $ 7,063 Net cash used in operating activities for the three months ended March 31, 2023 was $31,725 compared with net cash used in operating activities of $38,788 for the three months ended March 31, 2022. The decrease in net cash used in operating activities was primarily due to an increase of $6,289 in accounts payable and accrued expenses for the three months ended March 31, 2023, compared to a decrease in accounts payable and accrued expenses of $3,131 for the three months ended March 31, 2022. 11 Net cash used in operating activities for the three months ended March 31, 2023 was $38,788, representing a net loss of $50,379 partially offset by an increase of $12,500 in accrued royalties and by an increase of $6,289 in accounts payable and accrued expenses. Effects of Inflation We do not believe that inflation has had a material impact on our business, sales, or operating results during the periods presented. Off-Balance Sheet Arrangements We currently do not have any off-balance sheet arrangements or financing activities with special-purpose entities. Critical Accounting Policies and Use of Estimates Critical accounting policies are those policies which are both important to the presentation of a company’s financial condition and results and require management’s most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. There have been no recent significant changes to our accounting policies and use of estimates during the three months ended March 31, 2023. For a further discussion of our critical accounting policies, see our Annual Report on Form 10-K for the fiscal year ended December 31, 2022. Forward-Looking Statements and Certain Factors That May Affect Future Results of Operations The Securities and Exchange Commission encourages companies to disclose forward-looking information so that investors can better understand a company’s future prospects and make informed investment decisions. This Quarterly Report on Form 10-Q contains such “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.All statements in this report, other than statements of historical fact, are forward-looking statements for purposes of these provisions, including any projections of earnings, revenues or other financial items, any statements of the plans and objectives of management for future operations, any statements concerning proposed new products or services, any statements regarding future economic conditions or performance, and any statements of assumptions underlying any of the foregoing. All forward-looking statements included in this report are made as of the date hereof and are based on information available to us as of such date. We assume no obligation to update any forward-looking statement. In some cases, forward-looking statements can be identified by the use of terminology such as “may,” “will,” “expects,” “plans,” “anticipates,” “intends,” “believes,” “estimates,” “potential,” or “continue,” or the negative thereof or other comparable terminology. Although we believe that the expectations reflected in the forward-looking statements contained herein are based upon reasonable assumptions at the time made, there can be no assurance that any such expectations or any forward-looking statement will prove to be correct. Our actual results will vary, and may vary materially, from those projected or assumed in the forward-looking statements. Future financial condition and results of operations, as well as any forward-looking statements, are subject to inherent risks and uncertainties, many of which we cannot predict with accuracy and some of which we might not anticipate, including, without limitation, product recalls and product liability claims; infringement of our technology or assertion that our technology infringes the rights of other parties; termination of supplier relationships, or failure of suppliers to perform; inability to successfully manage growth; delays in obtaining regulatory approvals or the failure to maintain such approvals; concentration of our revenue among a few customers, products or procedures; development of new products and technology that could render our products obsolete; market acceptance of new products; introduction of products in a timely fashion; price and product competition, availability of labor and materials, cost increases, and fluctuations in and obsolescence of inventory; volatility of the market price of our common stock; foreign currency fluctuations; changes in key personnel; work stoppage or transportation risks; integration of business acquisitions; and other factors referred to in our reports filed with the SEC, including our Registration Statement on Form 10. All subsequent forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by these cautionary statements. Additional factors that may have a direct bearing on our operating results are discussed in Item 1A “Risk Factors” in our Registration Statement on Form 10. In light of these assumptions, risks and uncertainties, the results and events discussed in the forward-looking statements contained in this Quarterly Report or in any document incorporated by reference might not occur. Stockholders are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date of this Quarterly Report. We are not under any obligation, and we expressly disclaim any obligation to update or alter any forward-looking statements, whether as a result of new information, future events or otherwise. All subsequent forward-looking statements attributable to us or to any person acting on our behalf are expressly qualified in their entirety by the cautionary statements contained or referred to in this section. 12